Pages

Wednesday, January 4, 2017

Radiopharmacies Celebrate the New Year with Long-Awaited FDA ...

JD Supra (press release)-22 hours ago
With regard to compounding, that constitutes “minor deviation” and repackaging, the guidance states that the FDA will not take action for violations of the FD&C ...